The Impact of Ketogenic Capacity on Lipid Profile in Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178566 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jaehyun Bae und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym University College…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Prediabetic State, Lipids. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korean Diabetes Association.
Themen: Diabetes mellitus
Abstract (Originalsprache)
In individuals with non-adipogenic traits and enhanced ketogenic capacity, plasma triglyceride (TG) levels are typically low, while low-density lipoprotein cholesterol (LDL-C) levels often exceed the normal range, complicating cardiovascular risk assessment. We analyzed lipid profiles to better characterize cardiovascular risk in this population. Drug-naïve patients newly diagnosed with prediabetes or type 2 diabetes (T2D) were divided into two groups based on serum β-hydroxybutyrate levels: enhanced versus non-enhanced ketogenesis. Among those with enhanced ketogenesis, 27 individuals with high LDL-C (≥100 mg/dL) and low TG (150 mg/dL) from the non-enhanced group were included. The enhanced ketogenesis group demonstrated more favorable lipid characteristics, including a significantly larger average LDL particle size (26.8 ± 0.3 nm vs. 25.9 ± 0.6 nm, p < 0.001), a lower proportion of small dense LDL particles, and reduced oxidized LDL to LDL-C ratio. Importantly, enhanced ketogenesis remained an independent predictor of larger LDL particle size after adjusting for potential confounders including TG. Despite the potential of selection bias intentionally induced by the predefined inclusion criteria, our findings suggest that patients with T2D or prediabetes who exhibit enhanced ketogenesis, even in the presence of elevated LDL-C levels, may have a more favorable atherogenic profile and are not necessarily at increased cardiovascular risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul 07441, Republic of Korea.
- Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Institute of Endocrine Research, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
ORCID-Profile: Jaehyun Bae, Minyoung Lee, Yong-Ho Lee, Sang-Guk Lee, Byung-Wan Lee
Förderung
- Korean Diabetes Association
Zitieren
APA
Bae, J., Lee, M., Lee, Y. H., Lee, S. G., & Lee, B. W. (2025). The Impact of Ketogenic Capacity on Lipid Profile in Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178566
Vancouver
Bae J, Lee M, Lee YH, Lee SG, Lee BW. The Impact of Ketogenic Capacity on Lipid Profile in Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178566
BibTeX
@article{Bae2025,
author = {Bae, Jaehyun and Lee, Minyoung and Lee, Yong-Ho and Lee, Sang-Guk and Lee, Byung-Wan},
title = {The Impact of Ketogenic Capacity on Lipid Profile in Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178566}
}
EUVIMED